bioRxivNeurosciencePreprint
From berries to brain: Assessing the impact of (poly)phenols in the MPTP mouse model of Parkinson's disease
Rafael CarechoiD, Ana RaimundoiD, María Ángeles Ávila‐GálveziD, H. Lopes, Catarina O. SequeiraiD, Carlos PitaiD, Catarina PintoiD, Diogo CarregosaiD, Alicia Marín, Antonio González‐SarríasiD, Juan Carlos Espı́niD, Sofia Azeredo PereiraiD, Andreia Neves CarvalhoiD, Teresa Faria PaisiD, Natasa LoncareviciD, Cláudia Nunes dos SantosiD
Abstract
The growing burden of chronic neurodegenerative diseases (NDs), particularly Parkinsons disease (PD), prompts the need for effective preventive strategies and treatments. Dietary (poly)phenols have emerged for their neuroprotective potential. This study investigated a (poly)phenol-enriched diet, comprising a berry mixture, to counteract key PD hallmarks in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice and elucidate the phenolic metabolic fingerprint underlying these effects. The berry-enriched diet prevented motor deficits in the MPTP mice model, preserved dopaminergic neurons in the midbrain, reduced glial activation and gene expression of inflammatory cytokines. Notably, berries also attenuated macrophage infiltration observed in the substantia nigra 7 days post-MPTP. Metabolomic analysis revealed distinct phenolic signatures in plasma and brain tissue between standard- and berry-fed mice. Overall, this pioneering study provides compelling evidence that a (poly)phenol-enriched diet may play a protective role in neurodegenerative disorders, highlighting its potential for future strategies to prevent or slow PD progression.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson's disease
Mitali Arun Tambe, Aurélie de Rus Jacquet, … Jean‐Christophe Rochet·AntioxidantsPeer-reviewed·Jul 20, 2023
- Synthetic neuromelanin as a trigger of inflammation in the brain, new mouse model of Parkinson's disease
Anna Tejchman, Martyna Strzelec, … Marcin Majka·bioRxiv·Apr 28, 2023
- Re-routing metabolism by the mitochondrial pyruvate carrier inhibitor MSDC-0160 attenuates neurodegeneration in a rat model of Parkinson's disease
David Mallet, Raphaël Goutaudier, … Sabrina Boulet·Molecular NeurobiologyPeer-reviewed·Jul 27, 2022
- Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinsons disease
- Rationally Designed PKD1 Activator Protects Against Neurodegeneration in Pre-clinical Models of Parkinson's Disease
Arunkumar Asaithambi, Ah-Young Jang, … Anumantha G. Kanthasamy·bioRxiv·Feb 13, 2025
- Sexually dimorphic responses to MPTP found in microglia, inflammation and gut microbiota in a progressive monkey model of Parkinson's disease
Valerie L. Joers, Gunasingh Jeyaraj Masilamoni, … Malú G. Tansey·bioRxiv·Jan 30, 2020